Medtronic received information regarding a pipeline flex with shield that failed to open.The patient was undergoing a procedure for flow diverter treatment of an unruptured amorphous giant internal carotid artery (ica) aneurysm.The aneurysm max diameter was 22mm and the neck diameter was 7mm.Vessel tortuosity was moderate.Dual antiplatelet treatment (dapt) was administered.It was reported that the pipeline and all accessory devices were prepared and used as indicated in the instructions for use (ifu).During deployment, the pipeline distal end did not open at first.After some time, it was able to be opened but then the proximal end did not open.The physician tried all recommended techniques per the device guidelines but the proximal end could not be opened.It was noted that the pipeline was not positioned in a bend.More than 50% of the pipeline was deployed when it failed to open.The pipeline was resheathed 2 or less times.No other steps or devices were used to open the pipeline.It was resheathed and removed with the microcatheter.A competitor's device was then used to complete the procedure.There was no harm or injury to the patient.
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|